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Chapter VIII . Coordinated regulation of cell adhesion by cell-binding domain
density and elastic modulus
Abstract
A family of artificial extracellular matrix (aECM) proteins that contain cell-binding
domains derived from fibronectin and structural domains derived from elastin is described.
These aECM proteins can be crosslinked into freestanding, three-dimensional films of
tunable elastic modulus.  Following crosslinking, the cell-binding domain sequences
incorporated into the aECM films can still promote sequence-specific adhesion of
endothelial cells.  This cell adhesion can be tuned by altering the density of cell-binding
domains within the film and by modifying the elastic modulus of the film from 0.1 - 1.0
MPa.  The secretion and activation of matrix metalloproteinase-2 is also affected by elastic
modulus.  The ability to control both the cell-binding domain density and elastic modulus
independently suggests that aECM films are ideal substrates to investigate the coordinated
effects of biochemical and biomechanical cell-matrix interactions.  Furthermore, the ability
to tune the elastic modulus of aECM films to match that of native elastin while
simultaneously promoting endothelial cell adhesion suggests that aECM proteins may be
useful as small-diameter vascular grafts.
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1. Introduction
Anchorage of cells to the underlying substrate plays a key role in determining cell
structure and function [1].  One key criterion for small-diameter vascular grafts is the firm
adhesion of endothelial cells to the graft material in the face of opposing hemodynamic
forces [2, 3]. Our previous work has shown that endothelial cells can adhere strongly to
films of adsorbed artificial extracellular matrix (aECM) proteins in a sequence-specific
manner that resists physiologically relevant detachment forces [4]. This work validated the
hypothesis that endothelial cell adhesion strength can be controlled by appropriate
molecular engineering of aECM proteins.  We now extend this hypothesis to suggest that
the recognition of cellular domains and the observed effects on endothelial cell spreading
and adhesion are retained upon crosslinking of aECM proteins into films suitable for
construction of freestanding, implantable vascular grafts.
As reported previously, several crosslinking chemistries have emerged as providing
tunable mechanical properties for aECM films [5, 6].  Recent studies suggest that in
addition to recognizing ECM ligands, cells also respond to the mechanical properties of
their surroundings by regulating adhesive interactions [7].  Rigid matrices, when compared
to compliant matrices of identical composition, promote cell-surface assembly of fibronectin
[8], decrease cell locomotion [9], display increased levels of protein phosphorylation at sites
of cell-matrix contact [10], and strengthen integrin-cytoskeleton linkages [11].  Mounting
evidence suggests that a balance of forces is maintained across the cell-matrix interface that
is affected by many intracellular and extracellular components and provides a mechanical
context for cellular response [12, 13].  Therefore, this work studies the effects of matrix
rigidity as well as cell-binding domain density on endothelial cell spreading and adhesion
on crosslinked aECM proteins.
Following arterial injury, which includes interventions for occlusive vascular disease,
endothelial cells and smooth muscle cells play important roles in the hyperplastic response
which includes cell migration into the intima along with secretion of ECM components and
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matrix metalloproteinases (MMPs) [14].  Wound repair can be characterized by cell
migration and consequent tissue remodeling by the secretion and activation of MMP
molecules [15, 16].  Recent studies have been devoted to the regulation of MMPs by
endothelial cells in order to understand the underlying mechanisms governing angiogenesis
[17].  This work has shown that integrin recognition events as well as substrate mechanical
properties may influence the secretion and activation of these important molecules [18-20].
Integrins of the b1-subfamily as well as the avb3 and avb5 integrins are known to be
involved in the signaling of matrix molecules during angiogenesis [21].  We believe that
much of this work can be extended to aECM proteins to gain an understanding of how
endothelial cells respond to local wounds inflicted during vascular grafting.  Currently, the
optimum endothelial cell response to encourage re-endothelialization and wound healing of
a vascular graft is unknown.   We hypothesize that the secretion and activation of various
MMP molecules can be modulated through genetic engineering of the aECM protein and
subsequent crosslinking to tune the mechanical properties.
The amino acid sequences of the aECM proteins used in this work are shown in
Figure 1. Each includes elastin-like repeats comprising the pentapeptide VPGIG,
interspersed with the CS5 or RGD cell-binding domains of fibronectin (termed REDV and
RGD, respectively.)  The REVD and RDG protein sequences are identical except the
minimal recognition sites have been scrambled to provide negative control substrates for
cell-binding studies. The elastin-like sequences give these materials elasticity and
mechanical integrity [5, 6] while the cell-binding domains provide cell adhesion signals [4,
22]. Lysine residues were incorporated into each sequence to allow site-specific
crosslinking without interruption of the cell-binding domains. A T7-tag leader sequence is
included to increase expression levels and to aid in protein detection. A hexahistidine tag
was incorporated as an alternate method of purification along with an enzymatic cleavage
site to remove the fusion sequences.
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Figure 1.  Amino acid sequences of the artificial extracellular matrix proteins.  Each protein contains three
cassettes of a cell-binding domain interspersed with elastin-like domains.   The REDV and RGD proteins
contain the CS5 and RGD cell-binding domains, respectively, while the REVD  and RDG  proteins are
negative controls with scrambled cell-binding domains.
2. Experimental section
2.1. Protein expression and purification
Plasmids encoding sequences REDV , REVD , RGD , and RDG  have been
previously described[5, 22].  These sequences were expressed in E. coli and purified as
previously described [4, 22].  Purity was assessed by SDS-PAGE, mass spectrometry, and
Western blotting with anti-T7 tag-horseradish peroxidase conjugate antibody (Amersham).  
2.2. Protein crosslinking
Protein films, 20% wt/vol in phosphate buffered saline (PBS), were crosslinked by
addition of bis(sulfosuccinimidyl) suberate (BS3) pre-solubilized in 4°C water prior to
injection in a 96-well plate (15 ml/well) and centrifugation at 4°C for 15 min.  Plates were
covered with sealing tape and incubated 10 hours at 4°C prior to rinsing three times with
PBS.  Films were blocked with 0.2% heat-inactivated bovine serum albumin (BSA fraction
V, Sigma) for 30 min and rinsed three times with PBS.
REDV:
M-MASMTGGQQMG-HHHHHHH-DDDDK-{LD-GEEIQIGHIPREDVDYHLYP-G[(VPGIG)2VPGKG(VPGIG)2]4VP}3-LE
REVD:
M-MASMTGGQQMG-HHHHHHH-DDDDK-{LD-GEEIQIGHIPREVDDYHLYP-G[(VPGIG)2VPGKG(VPGIG)2]4VP}3-LE
RGD:
M-MASMTGGQQMG-HHHHHHH-DDDDK-{LD-YAVTGRGDSPASSKPIA-G[(VPGIG)2VPGKG(VPGIG)2]4VP}3-LE
RDG:
M-MASMTGGQQMG-HHHHHHH-DDDDK-{LD-YAVTGRDGSPASSKPIA-G[(VPGIG)2VPGKG(VPGIG)2]4VP}3-LE
T7 tag
T7 tag His tag
His tag
Cleavage
site
Cleavage
site
Scrambled REVD binding domain
REDV binding domain Elastin-like domain
Elastin-like domain
T7 tag His tag Cleavage
site
RGD binding domain Elastin-like domain
T7 tag His tag Cleavage
site
Scrambled RDG binding domain Elastin-like domain
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2.3. Cell culture
Human umbilical vein endothelial cells (HUVEC, Bio Whittaker) were maintained in
a 37°C, 5% CO2 humidified environmental chamber.  The cells were grown in Endothelial
Growth Medium-2 (5% serum, Bio Whittaker) and passaged non-enzymatically by
treatment with 0.61 mM EDTA (Gibco).  Passages 2-10 were used.
2.4. Cell resistance to detachment
Prior to each assay, a background fluorescence measurement of the crosslinked
protein films was taken using a Perkin Elmer HTS 7000 Bio Assay Reader with excitation
at 485 nm and emission at 538 nm.  HUVEC in suspension were then labeled with a 5 mM
solution of calcein acetoxymethyl ester (Molecular Probes) in serum-free Endothelial Basal
Medium (EBM, Cell Applications, San Diego, CA) at room temperature for 30 min.  Cells
were rinsed twice and resuspended in EBM at 2.67x105 cell/ml.  Cells (150 ml/well) were
added to crosslinked films in 96-well plates in the presence or absence of competitive
peptides.  Competitive peptides (GRGDSP and GRDGSP) were provided at a concentration
of 1.8 mM.  After incubation at 37°C (for 30 min unless otherwise noted), the wells were
completely filled with PBS and an initial fluorescence reading was measured prior to
covering with sealing tape, inverting the plate, and centrifuging at 100 g for 10 min.  After
centrifugation, the sealing tape was removed and the fluorescence was again recorded.  The
detachment force applied was estimated to be 26 pN using Archimedes’ theorem [22].
Three independent experiments with six replicates each were performed.  Cell retention is
calculated as
Final fluorescence - Background fluorescence     x 100%.
Initial fluorescence - Background fluorescence
2.5. Zymography
Samples of 16-hour conditioned medium were collected from HUVEC monolayers
grown on crosslinked protein films.  The samples were analyzed by gelatin zymography
prior to densitometry analysis using Image J software (public domain image analysis
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software provided by NIH).  Briefly, samples were run at 200 V at 4°C on a 10% SDS-
PAGE impregnated with 1 mg/ml gelatin.  The gel was washed twice with 2.5% TritonX-
100 and incubated overnight at 37°C in an activation buffer (50 mM TrisHCl, 5mM CaCl2,
1mM ZnCl2, 1% TritonX-100, 0.02% NaN3).  After staining, the majority of the gel is tinted,
representing the impregnated gelatin, while clear bands represent gelatin degradation caused
by MMPs in the conditioned medium.   Three independent experiments were performed.
3. Results and discussion
3.1. Sequence-specific  cell adhesion
Prior studies have shown that human umbilical vein endothelial cells (HUVEC)
adhere to aECM proteins primarily through interactions with the cell-binding domains when
the proteins are adsorbed to tissue culture polystyrene [4, 22].  Interestingly, HUVEC
adhere more strongly to the RGD protein after it has been crosslinked into a coherent film,
Figure 2.  This increase in cell retention is probably not the result of an increase in cell-
binding domain concentration, because the adsorbed RGD substrate already presents over
two-orders of magnitude more cell-binding domains as potential cell-surface receptors.
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Figure 2. HUVEC retention on RGD presented as a crosslinked, coherent film or as an adsorbed protein
substrate after 30 min of adhesion time and 10 min of exposure to a 26 pN detachment force.  Three
independent experiments were performed.  Error bars represent one standard deviation.
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To verify that cell adhesion was primarily a result of interactions with the RGD
minimal binding sequence, the adhesion assay was repeated in the presence and absence of
competitive peptides.  As expected, the GRGDSP peptide almost completely inhibited
HUVEC binding to crosslinked films of RGD while the scrambled sequence GRDGSP
peptide was found to have no effect on cell retention, Figure 3.
Figure 3.  HUVEC retention following 30 min of adhesion time and 10 min exposure to a 26 pN
detachment force on crosslinked RGD and RDG films in the presence and absence of competitive peptides.
Three independent experiments were performed.  Error bars represent one standard deviation.
Previous studies of cell spreading on aECM proteins found that HUVEC were fully
spread on adsorbed RGD substrates after 30 min while HUVEC on adsorbed REDV
substrates required much longer times for cell spreading to occur [22].  This contrast in cell
spreading times was also found in comparisons of crosslinked RGD and REDV films,
Figures 3 and 4.  While 30 min of incubation was sufficient to retain about 30% of
HUVEC on crosslinked RGD throughout 10 min of exposure to a 29 pN detachment force
(Figure 3), fewer than 5% of HUVEC remained adherent during a similar force after 30 min
of incubation on REDV (data not shown).  HUVEC were required to incubate on REDV
films for about 2 hours before this level of cell adhesion was demonstrated, Figure 4.
However, at even longer incubation times, cell adhesion was observed to decrease.  This is
perhaps attributable to interactions between the CS5 cell-binding domain and the a4b1
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integrin, which has been shown to promote weak adhesion and increase cell migration [23].
At 2 hours, cell adhesion to the negative control REVD film was significantly less than
adhesion to REDV.  Collectively, these results demonstrate that HUVEC are able to
recognize the cell-binding domain sequences incorporated into the engineered REDV and
RGD proteins even after crosslinking into coherent films.
Figure 4.  HUVEC retention on crosslinked REDV and REVD films following two or three hours of
incubation prior to 10 min exposure to a 26 pN detachment force.  These are preliminary results that have
been repeated twice.  Error bars represent one standard deviation.
3.2. Tuning cell adhesion through material properties
Two material properties were evaluated for their ability to tune cell adhesion:  cell-
binding domain density and elastic modulus.  The cell-binding domain density was
modified by mixing together RGD and RDG proteins at various concentrations prior to
crosslinking.  Decreasing the concentration of RGD in the film from 100 - 90% resulted in
a decrease in cell retention of over 50%, Figure 5.  No significant changes in cell retention
were observed for films from 90 -50% RGD.  These changes in cell adhesion simply could
be a result of the decrease in density of the cell-binding domain or could be affected by the
local spatial arrangement of the RGD domains.  These crosslinked aECM films are
0
5
10
15
20
25
30
35
2 hours 3 hours
Incubation Time
C
el
l 
R
et
en
ti
on
 (
%
)
REDV
REVD
VIII-9
assumed to be homogenous; therefore, a decrease in cell-binding domain density will also
result in larger spacing between adjacent binding motifs.
Figure 5.  HUVEC retention on crosslinked films made of mixtures of RGD  and RDG  after 30 min
incubation and 10 min exposure to a 26 pN detachment force.  These are preliminary results that have been
repeated twice.  Error bars represent one standard deviation.
To vary the elastic modulus of the materials, the proteins were crosslinked with
various stoichiometric amounts of BS3 crosslinker.  Previous reports have shown that
elastic modulus is approximately linearly dependent on crosslinker stoichiometry up to one
full stoichiometric ratio [5].  Films prepared with 1X stoichiometric amount of BS3 results
in a film with an elastic modulus about 0.7 MPa, similar to that of native elastin.  HUVEC
were found to adhere more firmly after a 30 min incubation to films prepared with higher
stoichiometric ratios of BS3, Figure 6.  This result is somewhat similar to reports by others
that cells display larger spread areas and increased adhesion and intracellular signalling on
stiffer substrates; however, these reports were generally concerning materials with elastic
moduli 10-100X less than those tested here [7-11].
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Figure 6.  HUVEC retention on films of RGD  and RDG prepared with 1 - 0.25 stoichiometric amount of
BS3 crosslinker.  These are preliminary results that have been repeated twice.  Error bars represent one
standard deviation.
3.3. Matrix metalloproteinase-2 activation
Matrix metalloproteinase-2 (MMP-2) is a gelatinase secreted and activated by
endothelial cells.  Medium samples were taken from HUVEC monolayers grown on
crosslinked aECM films for 16 hours and analyzed by gelatin zymography, Figure 7.
Crosslinked aECM films of REDV  and REVD  were formed using 0.5 or 1.0
stoichiometric amount of BS3 crosslinker, resulting in films with elastic modulus of about
0.1 and 0.3 MPa, respectively [5, 24].  The clear bands represent degradation of gelatin,
which was impregnanted in the acrylamide gel, by proteases.  In lanes one and three (films
with 0.5X BS3), three bands are present at 72, 62, and 59 kDa, corresponding to the inactive,
partially active, and fully active forms of MMP-2, respectively [18, 19, 25].  In contrast,
lanes two and four (films with 1.0X BS3) only have bands at 72 kDa, suggesting that all
secreted MMP-2 on these substrates is in the inactive form.  MMP-2 secretion and
activation were increased on films with lower elastic moduli, irrespective of whether the
authentic or scrambled CS5 cell-binding domain sequence was presented.  These results
were quantified using densitometry and are reported in Table 1.  The intensity values in
Table 1 are reported relative to the intensity of the brightest band (inactive MMP-2 secretion
on a REVD film with 0.5X crosslinker).  These results corroborate earlier studies that
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showed endothelial cells increase MMP-2 activation and undergo less cytoskeleton
remodeling when grown on flexible substrates [18, 19].  Taken together with the results in
Figure 6, these data suggest that HUVEC grown on more compliant films undergo less
cytoskeleton remodeling which results in weaker resistance to detachment forces and
increased secretion and activation of MMP-2.
Figure 7.  Gelatin zymogram of conditioned medium samples taken from HUVEC grown on various aECM
films for 16 hours.  Films were prepared from REDV and REVD  proteins with either 0.5 or 1.0
stoichiometric amount of BS3.
Table 1. MMP-2 secretion and activation by HUVEC monolayers grown on various aECM films for 16
hours as measured by individual band intensity relative to the highest intensity band.
REDV REDV REVD REVD
Molecular weight MMP-2 form 0.5X 1.0X 0.5X 1.0X
72,000 inactive 75.4 24.0 100.0 31.0
62,000 partially active 2.3 0.0 5.0 0.0
59,000 fully active 2.2 0.0 1.6 0.0
      REDV            REVD       
 0.5X    1.0X     0.5X     1.0X
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4. Conclusion
Towards the goal of designing a new protein-based material for small-diameter
vascular grafts, we have previously shown that genetically engineered  artificial extracellular
matrix proteins can adhere endothelial cells in a sequence-specific manner  while physically
adsorbed to tissue culture polystyrene.  These proteins can also be crosslinked into
freestanding, three-dimensional structures with elastic moduli similar to that of native
elastin.  The work presented here demonstrates that this crosslinking procedure does not
inhibit sequence-specific endothelial cell adhesion.  HUVEC adhesion to these crosslinked
films can be tuned by controlling the density of cell-binding domains presented or by
modifying the elastic modulus.  Furthermore, secretion and activation of MMP-2 was
influenced by elastic modulus and not cell-binding domain authenticity.  These results
suggest that crosslinked aECM films may be useful as small-diameter vascular grafts and
also have potential as substrates for well-characterized studies of cell-matrix interactions.
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